Toll Free: 1-888-928-9744

Synthon BV - Product Pipeline Review - 2014

Published: Jun, 2014 | Pages: 29 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Synthon BV - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'Synthon BV - Product Pipeline Review - 2014', provides an overview of the Synthon BV's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Synthon BV's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Synthon BV including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Synthon BV's human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Synthon BV's pipeline products

Reasons to buy

- Evaluate Synthon BV's strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Synthon BV in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Synthon BV's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Synthon BV and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Synthon BV
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Synthon BV and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
 Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Synthon BV Snapshot 5
Synthon BV Overview 5
Key Information 5
Key Facts 5
Synthon BV - Research and Development Overview 6
Key Therapeutic Areas 6
Synthon BV - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Pipeline Products - Out-Licensed Products 10
Out-Licensed Products/Combination Treatment Modalities 11
Synthon BV - Pipeline Products Glance 12
Synthon BV - Early Stage Pipeline Products 12
Preclinical Products/Combination Treatment Modalities 12
Discovery Products/Combination Treatment Modalities 13
Synthon BV - Drug Profiles 14
Secretory IgA 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
SYD-985 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
Biosimilar-2 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
Immunotherapeutic IgG 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
Monoclonal Antibody Conjugated 2 for Oncology 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
Monoclonal Antibody Conjugated 3 for Oncology 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
Monoclonal Antibody Conjugated 4 For Oncology 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
Synthon BV - Pipeline Analysis 21
Synthon BV - Pipeline Products by Target 21
Synthon BV - Pipeline Products by Molecule Type 22
Synthon BV - Pipeline Products by Mechanism of Action 23
Synthon BV - Recent Pipeline Updates 24
Synthon BV - Dormant Projects 25
Synthon BV - Company Statement 26
Synthon BV - Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Appendix 28
Methodology 28
Coverage 28
Secondary Research 28
Primary Research 28
Expert Panel Validation 28
Contact Us 29
Disclaimer 29
List of Tables
Synthon BV, Key Information 5
Synthon BV, Key Facts 5
Synthon BV - Pipeline by Indication, 2014 7
Synthon BV - Pipeline by Stage of Development, 2014 8
Synthon BV - Monotherapy Products in Pipeline, 2014 9
Synthon BV - Out-Licensed Products in Pipeline, 2014 10
Synthon BV - Out-Licensed Products/ Combination Treatment Modalities, 2014 11
Synthon BV - Preclinical, 2014 12
Synthon BV - Discovery, 2014 13
Synthon BV - Pipeline by Target, 2014 21
Synthon BV - Pipeline by Molecule Type, 2014 22
Synthon BV - Pipeline Products by Mechanism of Action, 2014 23
Synthon BV - Recent Pipeline Updates, 2014 24
Synthon BV - Dormant Developmental Projects,2014 25
Synthon BV, Subsidiaries 27 



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify